EVOGENE LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 287.5 ILa | +7.44% |
|
+15.42% | -4.10% |
| 23/05 | Earnings Flash (EVGN) EVOGENE Posts Q1 Revenue $4.2M, vs. Street Est of $3.5M | MT |
| 23/05 | Transcript : Evogene Ltd., Q1 2024 Earnings Call, May 23, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 39.65M | - | - | - | |||
| 62.86B | - | |||||
| 41.38B | ||||||
| 40.38B | ||||||
| 27.64B | ||||||
| 26.46B |
- Stock Market
- Equities
- EVGN Stock
- Charts Evogene Ltd.
- Sector Chart
